• 沒有找到結果。

SYNDROMES, DISORDERS AND MATERNAL RISK FACTORS ASSOCIATED WITH NEURAL TUBE DEFECTS (III)

N/A
N/A
Protected

Academic year: 2022

Share "SYNDROMES, DISORDERS AND MATERNAL RISK FACTORS ASSOCIATED WITH NEURAL TUBE DEFECTS (III)"

Copied!
3
0
0

加載中.... (立即查看全文)

全文

(1)

Author(s): Chen, CP (Chen, Chih-Ping)

Title: SYNDROMES, DISORDERS AND MATERNAL RISK FACTORS ASSOCIATED WITH NEURAL TUBE DEFECTS (III)

Source: TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 47 (2): 131-140 JUN 2008

Language: English Document Type: Review

Author Keywords: congenital malformations; disorder; maternal risk factors; neural tube defects; syndromes

KeyWords Plus: ANUS-SPINAL DEFECTS; BODY-WALL COMPLEX; MECKEL-GRUBER- SYNDROME; PENTALOGY-OF-CANTRELL; POLYCYSTIC KIDNEY-DISEASE; ANTERIOR ABDOMINAL-WALL; SENIOR-LOKEN-SYNDROME; OEIS COMPLEX; JOUBERT-

SYNDROME; PRENATAL-DIAGNOSIS

Abstract: Fetuses with neural tube defects (NTDs) may be associated with syndromes, disorders, and maternal and fetal risk factors. This article provides a comprehensive review of syndromes, disorders, and maternal and fetal risk factors associated with NTDs, such as omphalocele, OEIS (omphalocele-exstrophy-imperforate anus-spinal defects) complex, pentalogy of Cantrell, amniotic band sequence, limb-body wall complex, Meckel syndrome, Joubert syndrome, skeletal dysplasia, diabetic embryopathy, and single nucleotide

polymorphisms in genes of glucose metabolism. NTDs associated with syndromes, disorders, and maternal and fetal risk factors are a rare but important cause of NTDs. The recurrence risk and the preventive effect of maternal folic acid Intake in NTDs associated with syndromes, disorders and maternal risk factors may be different from those of nonsyndromic multifactorial NTDs. Perinatal identification of NTDs should alert the clinician to the syndromes, disorders, and maternal and fetal risk factors associated with NTDs, and prompt a thorough etiologic investigation and genetic counseling. [Taiwan J Obstet Gynecol 2008;47(2):131-140]

Addresses: [Chen, Chih-Ping] Mackay Mem Hosp, Dept Obstet & Gynecol, Taipei, Taiwan;

[Chen, Chih-Ping] Mackay Mem Hosp, Dept Med Res, Taipei, Taiwan; [Chen, Chih-Ping] Asia Univ, Dept Biotechnol, Taichung, Taiwan; [Chen, Chih-Ping] China Med Univ, Coll Chinese Med, Sch Chinese Med, Taichung, Taiwan; [Chen, Chih-Ping] Natl Yang Ming Univ, Inst Clin &

Community Hlth Nursing, Taipei 112, Taiwan

Reprint Address: Chen, CP, Mackay Mem Hosp, Dept Obstet & Gynecol, 92,Sect 2,Chung Shan N Rd, Taipei, Taiwan.

E-mail Address: cpc_mmh@yahoo.com

Cited References: ARTS HH, 2007, NAT GENET, V39, P882, DOI 10.1038/ng2069.

BAALA L, 2007, AM J HUM GENET, V80, P186.

BAALA L, 2007, AM J HUM GENET, V81, P170, DOI 10.1086/519494.

(2)

BADANO JL, 2006, ANNU REV GENOM HUM G, V7, P125.

BENNERIAH Z, 2007, ULTRASOUND OBST GYN, V29, P170, DOI 10.1002/uog.3874.

BIANCHI DW, 2000, FETOLOGY, P761.

BICK D, 1988, AM J MED GENET, V30, P805.

BLACQUE OE, 2004, GENE DEV, V18, P1630, DOI 10.1101/gad.1194004.

BOGNONI V, 1999, J CLIN ULTRASOUND, V27, P276.

BRANCATI F, 2007, AM J HUM GENET, V81, P104, DOI 10.1086/519026.

BRONSHTEIN M, 1992, PRENATAL DIAG, V12, P831.

CALZOLARI E, 1997, AM J MED GENET, V72, P79.

CANTRELL JR, 1958, SURG GYNECOL OBSTET, V107, P602.

CAREY JC, 1978, BIRTH DEFECTS, V14, P253.

CARMI R, 1990, AM J MED GENET, V36, P109.

CARMI R, 1992, AM J MED GENET, V42, P90.

CHEN CP, 1996, GENET COUNSEL, V7, P193.

CHEN CP, 1997, AM J PERINAT, V14, P275.

CHEN CP, 2000, PRENATAL DIAG, V20, P1020.

CHEN CP, 2001, PRENATAL DIAG, V21, P418.

CHEN CP, 2002, ULTRASOUND OBST GYN, V19, P102.

CHEN CP, 2002, ULTRASOUND OBST GYN, V20, P94.

CHEN CP, 2005, PRENATAL DIAG, V25, P521, DOI 10.1002/pd.838.

CHEN CP, 2007, GENET COUNSEL, V18, P105.

CHEN CP, 2008, J CLIN ULTR IN PRESS.

DANE C, 2007, J POSTGRAD MED, V53, P146.

DAVIDSON CM, 2008, REPROD SCI, V15, P51, DOI 10.1177/1933719107309590.

DELOUS M, 2007, NAT GENET, V39, P875, DOI 10.1038/ng2039.

DENATH FM, 1994, J CLIN ULTRASOUND, V22, P351.

DHANASEKARAN N, 1999, SEMIN REPROD ENDOCR, V17, P167.

EGAN JFX, 1993, AM J PERINAT, V10, P327.

FERLAND RJ, 2004, NAT GENET, V36, P1008, DOI 10.1038/ng1419.

FERRANTE MI, 2006, NAT GENET, V38, P112, DOI 10.1038/ng1684.

FRANK V, 2008, HUM MUTAT, V29, P45, DOI 10.1002/humu.20614.

GARESKOG M, 2007, REPROD TOXICOL, V23, P63, DOI 10.1016/j.reprotox.2006.08.009.

GATTONE VH, 2004, ANAT REC PART A A, V277, P384, DOI 10.1002/ar.a.20022.

GHIDINI A, 1988, J ULTRAS MED, V7, P567.

GIBSON WT, 2006, CLIN GENET, V69, P400.

GIRZ BA, 1998, AM J PERINAT, V15, P15.

GUO JH, 2004, BIOCHEM BIOPH RES CO, V324, P922, DOI 10.1016/j.bbrc.2004.09.133.

(3)

HARRIS PC, 2007, KIDNEY INT, V72, P1421, DOI 10.1038/sj.ki.5002577.

HARTWIG NG, 1989, HUM PATHOL, V20, P1071.

HEILIG CW, 2003, P NATL ACAD SCI USA, V100, P15613, DOI 10.1073/pnas.2536196100.

HELOU J, 2007, J MED GENET, V44, P657, DOI 10.1136/jmg.2007.052027.

HERTZBERG BS, 2003, DIAGNOSTIC IMAGING F, P507.

HERVA R, 1984, TERATOLOGY, V29, P11.

HORI A, 1984, ACTA NEUROPATHOL, V65, P158.

JAPAJOE SMEAA, 2003, AM J MED GENET A A, V118, P64, DOI 10.1002/ajmg.a.10262.

JENSEN PJ, 2006, J BIOL CHEM, V281, P13382, DOI 10.1074/jbc.M601881200.

JONES KL, 2006, SMITHS RECOGNIZABLE, P18.

KAPLAN LC, 1985, AM J MED GENET, V21, P187.

KEPPLERNOREUIL K, 2007, AM J MED GENET A A, V143, P2122, DOI 10.1002/ajmg.a.31897.

KEPPLERNOREUIL KM, 2001, AM J MED GENET, V99, P271.

KOSAKI R, 2005, AM J MED GENET A A, V135, P224, DOI 10.1002/ajmg.a.30733.

KRAMERZUCKER AG, 2005, DEVELOPMENT, V132, P1907, DOI 10.1242/dev.01772.

KUTZNER DK, 1988, PRENAT DIAGN, V8, P247.

KYTTALA M, 2006, NAT GENET, V38, P155, DOI 10.1038/ng1714.

LEE DH, 1999, AM J MED GENET, V84, P29.

LI DZ, 2006, AM J MED GENET A A, V140, P1476, DOI 10.1002/ajmg.a.31293.

LIN HJ, 1993, AM J MED GENET, V45, P761.

LIZCANOGIL LA, 1995, ARCH MED RES, V26, P95.

LOUREIRO T, 2007, FETAL DIAGN THER, V22, P172, DOI 10.1159/000098710.

LYNCH SA, 1995, NAT GENET, V11, P93.

MAJEWSKI N, 2004, MOL CELL, V16, P819.

MALGURIA N, 1996, J POSTGRAD MED, V42, P55.

MANSOUR E, 2006, ENDOCRINOLOGY, V147, P5470, DOI 10.1210/en.2006-0223.

MARTINEZFRIAS ML, 2001, AM J MED GENET, V99, P261.

MCGAHAN JP, 2003, DIAGNOSTIC IMAGING F, P291.

MCLAUGHLIN JF, 1984, AM J MED GENET, V19, P721.

MEIZNER I, 1985, AM J OBSTET GYNECOL, V153, P802.

MILLS JL, 2005, AM J MED GENET A A, V136, P8, DOI 10.1002/ajmg.a.30772.

MORGAN NV, 2002, HUM GENET, V111, P456, DOI 10.1007/s00439-002-0817-0.

NAULI SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076.

NAUTA J, 2000, J AM SOC NEPHROL, V11, P2272.

NOACK F, 2005, FETAL DIAGN THER, V20, P346, DOI 10.1159/000086810.

NYE JS, 2000, TERATOLOGY, V61, P165.

(4)

OTTO EA, 2005, NAT GENET, V37, P282, DOI 10.1038/ng1520.

PAAVOLA P, 1995, NAT GENET, V11, P213.

PAAVOLA P, 1999, GENOME RES, V9, P267.

PAMPFER S, 1997, DIABETES, V46, P1214.

PARISI MA, 2004, AM J HUM GENET, V75, P82.

PARVARI R, 1996, AM J MED GENET, V61, P401.

PAZOUR GJ, 2000, J CELL BIOL, V151, P709.

PEER D, 1993, ULTRASCHALL MED, V14, P94.

POLAT I, 2005, J CLIN ULTRASOUND, V33, P308, DOI 10.1002/jcu.20134.

REECE EA, 1999, SEMIN REPROD ENDOCR, V17, P183.

REECE EA, 2005, AM J OBSTET GYNECOL, V192, P967, DOI 10.1016/j.ajog.2004.10.592.

REECE EA, 2006, AM J OBSTET GYNECOL, V194, P580, DOI 10.1016/j.ajog.2005.08.052.

REECE EA, 2006, AM J OBSTET GYNECOL, V195, P1075, DOI 10.1016/j.ajog.2006.05.054.

REECE EA, 2008, J MATERN-FETAL NEO M, V21, P173, DOI 10.1080/14767050801929885.

REECE EA, 2008, REPROD SCI, V15, P7, DOI 10.1177/1933719107313050.

REYESMUGICA M, 1992, AM J MED GENET, V44, P540.

ROUME J, 1998, AM J HUM GENET, V63, P1095.

RUANO R, 2003, PRENATAL DIAG, V23, P539, DOI 10.1002/pd.638.

RUSSO R, 1993, AM J MED GENET, V47, P893.

SALONEN R, 1984, AM J MED GENET, V18, P671.

SAYER JA, 2006, NAT GENET, V38, P674, DOI 10.1038/ng1786.

SCHEMM S, 2003, ULTRASOUND OBST GYN, V22, P95, DOI 10.1002/uog.126.

SHANSKE AL, 2003, BIRTH DEFECTS RES A, V67, P467, DOI 10.1002/bdra.10058.

SIEBERT JR, 2005, PEDIATR DEVEL PATHOL, V8, P339, DOI 10.1007/s10024-005-1157-6.

SMITH NM, 1992, J MED GENET, V29, P730.

SMITH UM, 2006, NAT GENET, V38, P191, DOI 10.1038/ng1713.

SOPER RT, 1964, J UROLOGY, V92, P490.

SOPER SP, 1986, PEDIATR PATHOL, V5, P481.

SPITZ L, 1975, J PEDIATR SURG, V10, P491.

THAUVINROBINET C, 2004, AM J MED GENET A A, V126, P303, DOI 10.1002/ajmg.a.20596.

TORPIN R, 1965, AM J OBSTET GYNECOL, V91, P65.

TOYAMA WM, 1972, PEDIATRICS, V50, P778.

VALENTE EM, 2006, NAT GENET, V38, P623, DOI 10.1038/ng1805.

VANALLEN MI, 1987, AM J MED GENET, V28, P529.

VANALLEN MI, 1987, AM J MED GENET, V28, P549.

(5)

VASUDEVAN PC, 2006, PRENATAL DIAG, V26, P267, DOI 10.1002/pd.1394.

WITTERS I, 2004, ULTRASOUND OBST GYN, V24, P797, DOI 10.1002/uog.1776.

WU JL, 2004, J ULTRAS MED, V23, P1211.

YANG P, 2008, AM J OBSTET GYNECOL, V198.

YANG PX, 2007, BIOCHEM BIOPH RES CO, V357, P749, DOI 10.1016/j.bbrc.2007.04.023.

Cited Reference Count: 116 Times Cited: 1

Publisher: ELSEVIER SINGAPORE PTE LTD

Publisher Address: 3 KILLINEY ROAD 08-01, WINSLAND HOUSE 1, SINGAPORE, 239519, SINGAPORE

ISSN: 1028-4559

29-char Source Abbrev.: TAIWAN J OBSTET GYNECOL ISO Source Abbrev.: Taiwan. J. Obstet. Gynecol.

Source Item Page Count: 10

Subject Category: Obstetrics & Gynecology ISI Document Delivery No.: 371GH

參考文獻

相關文件

Crystal-storing histiocytosis (CSH), a rare condition in which crystalline material accumulates in the cytoplasm of histiocytes, is typically associated with disorders that

(1) Crystal-storing histiocytosis (CSH), a rare condition in which crystalline material accumulates in the cytoplasm of histiocytes, is typically associated with disorders that

The aim of this article is to review the management of oral leukoplakia. The topics of interest are clinical diagnosis, methods of management and their outcome, factors associated

SUMMARY The purpose of this systematic review was to describe the prevalence of whiplash trauma in patients with temporomandibular disorders (TMDs) and to describe clinical signs

The great majority of HPV relate SCC of the OP is nonkeratinizing as described above. However, more re- cently increasing numbers of variants of squamous cell carcinoma,

Accurate identification of the microscopic risk factors of oral and oropharyngeal (OP) squamous cell carcinomas (SCC) and their morphologic variants is of at most importance, as

Diagnostic considerations prior to histologic examination include idiopathic orofacial granulomatosis; syndromes pre- senting with multiple mucosal swellings, such as

Clinical findings and risk factors to oral squamous cell carcinoma in young patients: A 12-year retrospective analysis.. Hellen-Bandeira-de-Pontes Santos 1 , Thayana-Karla-Guerra